Cytokine Alterations and Chronic Post-Surgical Pain

Not yet recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2026

Primary Completion Date

December 1, 2028

Study Completion Date

December 31, 2028

Conditions
Chronic Post Operative Pain
Interventions
OTHER

Unilateral thoracotomy

Unilateral thoracotomy to proceed as per standard of care guidelines. Thoracic epidural analgesia, or patient controlled analgesia (PCA) pumps will be offered to each study participant as per standard of care. Pre- and post-operative (post-operative day 1 and 3 months) pain scores and blood samples will be collected. Blood samples will be analyzed to determine the concentration of cytokines, chemokines, and growth factors that are potentially associated with CPSP (epidermal growth factor, eotaxin, fibroblast growth factor basic, G-CSF, GM-CSF, human growth factor, IFN-α, IFN-γ, IL-1ra, IL-1β, IL-2, IL-2r, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 (p40/p70), IL-13, IL-15, IL-17, IP-10, MCP-1, MIG, MIP-1α, MIP-1β, RANTES, TNF-α, and VEGF). DNA promotor methylation for these targets will also be investigated.

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT06418295 - Cytokine Alterations and Chronic Post-Surgical Pain | Biotech Hunter | Biotech Hunter